<PAGE> 1
<TABLE>
<CAPTION>
<S> <C>
OMB APPROVAL
OMB Number: 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per response...14.90
</TABLE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 5 )*
AMERICAN ELECTROMEDICS CORP.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.10 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
025569-203
- --------------------------------------------------------------------------------
(CUSIP Number)
John M. Liviakis, 495 Miller Avenue, 3rd Floor, Mill Valley, CA 94941,
(415) 389-4670
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
October 1, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or
240.13d-1(g), check the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Section 240.13d-7
for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED
IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY
VALID OMB CONTROL NUMBER
<PAGE> 2
CUSIP No. 025569-203 SCHEDULE 13D
---------------------
(1) Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
Liviakis Financial Communications, Inc. 68-0311399
---------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ X ]
---------------------------------------------------------------------
(3) SEC Use Only
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
OO, WC
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
---------------------------------------------------------------------
(6) Citizenship or Place of Organization
California
---------------------------------------------------------------------
(7) Sole Voting Power
Number of 668,771
Shares --------------------------------------------------------
Beneficially (8) Shared Voting Power
Owned by -
Each --------------------------------------------------------
Reporting (9) Sole Dispositive Power
Person With 668,771
--------------------------------------------------------
(10) Shared Dispositive Power
-
--------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
668,771
---------------------------------------------------------------------
(12) Check Box if Aggregate Amount in Row (11) Excludes Certain
Shares* [X]
---------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
7.6%
---------------------------------------------------------------------
(14) Type of Reporting Person*
CO
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
2
<PAGE> 3
CUSIP No. 025569-203 SCHEDULE 13D
---------------------
(1) Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
John M. Liviakis
---------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ X ]
---------------------------------------------------------------------
(3) SEC Use Only
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
OO, PF
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
---------------------------------------------------------------------
(6) Citizenship or Place of Organization
United States
---------------------------------------------------------------------
(7) Sole Voting Power
Number of 10,000
Shares --------------------------------------------------------
Beneficially (8) Shared Voting Power
Owned by 668,771
Each --------------------------------------------------------
Reporting (9) Sole Dispositive Power
Person With 10,000
--------------------------------------------------------
(10) Shared Dispositive Power
668,771
--------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
678,771
---------------------------------------------------------------------
(12) Check Box if Aggregate Amount in Row (11) Excludes Certain
Shares* [ ]
---------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
7.7%
---------------------------------------------------------------------
(14) Type of Reporting Person*
IN
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
3
<PAGE> 4
CUSIP No. 025569-203 SCHEDULE 13D
---------------------
(1) Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
Renee A. Liviakis
---------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ X ]
---------------------------------------------------------------------
(3) SEC Use Only
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
OO
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
---------------------------------------------------------------------
(6) Citizenship or Place of Organization
United States
---------------------------------------------------------------------
(7) Sole Voting Power
Number of -
Shares --------------------------------------------------------
Beneficially (8) Shared Voting Power
Owned by 668,771
Each --------------------------------------------------------
Reporting (9) Sole Dispositive Power
Person With -
--------------------------------------------------------
(10) Shared Dispositive Power
668,771
--------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
668,771
---------------------------------------------------------------------
(12) Check Box if Aggregate Amount in Row (11) Excludes Certain
Shares* [X]
---------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
7.6%
---------------------------------------------------------------------
(14) Type of Reporting Person*
IN
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
---------------------------------------------------------------------
4
<PAGE> 5
1. SECURITY AND ISSUER.
The title of the class of equity securities to which this statement
relates is common stock, par value $.10 per share (the "Common Stock"), issued
by American Electromedics Corp., a Delaware corporation (the "Corporation"). The
principal offices of the Corporation are located at 13 Columbia Drive, Suite 18,
Amherst, New Hampshire 03031.
2. IDENTITY AND BACKGROUND.
This amended statement is filed by Liviakis Financial Communications,
Inc., a California corporation ("LFC"), John M. Liviakis ("JML"), and Renee A.
Liviakis ("RAL"). LFC's principal business is as a consultant in the areas of
financial and investor public relations, investor communications, and corporate
finance. LFC's principal business and principal office address is 495 Miller
Avenue, Mill Valley, California 94941.
LFC's President is JML and its Treasurer, Chief Financial Officer and
Secretary is RAL. JML and RAL are the only executive officers of LFC. The
activities associated with these positions constitute the principal occupation
and employment of JML and RAL. JML and RAL are LFC's only directors, and JML and
RAL are its sole stockholders. JML and RAL are citizens of the United States,
and their business address is LFC's principal business address listed above.
During the last five years, none of LFC, JML and RAL has been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors),
and during such period none of them has been a party to a civil proceeding of a
judicial or administrative body of competent jurisdiction, the result of which
was to subject such person to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
This Amended Schedule 13D is being filed to report (i) 668,771 shares of
Common Stock held by LFC on September 30, 1999 and (ii) 10,000 shares of Common
Stock held by JML on September 30, 1999.
Pursuant to a Consulting Agreement dated February 19, 1998 and effective
as of March 16, 1998 between the Corporation and LFC (the "Consulting
Agreement"), the Corporation on or about March 16, 1998 issued (i) 750,000
shares of Common Stock to LFC and (ii) a Common Stock Purchase Warrant to
purchase up to 750,000 shares of Common Stock to LFC (the "LFC Warrant"). The
LFC Warrant was exercisable from March 16, 1998 through March 16, 2002 at an
exercise price of $1.00 per share. Under the Consulting Agreement, LFC undertook
to perform certain investor communications,
5
<PAGE> 6
financial and investor public relations, corporate finance and related services
for the Corporation. A copy of the Consulting Agreement is Exhibit "A" to this
Schedule 13D.
Between March 23 and March 26, 1998, LFC purchased 39,000 shares of
Common Stock in the open market for aggregate consideration of $182,846.11. The
source of funds for such purchase was LFC's working capital.
On April 21, 1998, JML purchased 10,000 shares of Common Stock in the
open market for aggregate consideration of $35,804.09. The source of funds for
such purchase was JML's personal funds.
On December 15, 1998, LFC engaged in a "cashless" exercises of the LFC
Warrant. In lieu of paying the $750,000 aggregate cash exercise price for the
750,000 shares that could be purchased pursuant to the LFC Warrant, LFC directed
the Corporation to retain 307,629 of the shares, having a market value of
$750,000, as consideration for the exercise of the LFC Warrant and to issue to
LFC the balance of 442,371 shares of Common Stock.
From April through the end of October 1999, LFC has sold an aggregate of
562,600 shares of Common Stock in the open market.
5. INTEREST IN SECURITIES OF THE ISSUER.
LFC has the sole power to direct the vote or disposition of the 668,771
shares of Common Stock owned by LFC. LFC would exercise its power to direct the
vote or disposition of such shares through its officers and directors, JML and
RAL. JML has the sole power to direct the vote or disposition of the 10,000
shares of Common Stock owned by JML. LFC disclaims any beneficial interest in
any shares of Common Stock owned by JML.
The 668,771 shares of Common Stock that LFC owns, and as to which LFC
has the sole power to direct the vote or disposition, represent approximately
7.6% of that class of securities. The 10,000 shares of Common Stock that JML
owns, and as to which JML has the sole power to direct the vote or disposition,
represent approximately 0.1% of that class of securities. In each case, the
calculation of the percentage of Common Stock is based on the 8,765,220 shares
of Common Stock which the Corporation reported were outstanding on June 10,
1999.
Since the most recent previous amendment to this Schedule 13D, JML and
RAL have not engaged directly in any transactions in Common Stock, and LFC has
engaged in the following transactions:
A. On October 1, 1999, LFC sold 87,000 shares of Common Stock in the
over-the-counter market at a price of $1.07 per share.
6
<PAGE> 7
B. On October 1, 1999, LFC sold 5,000 shares of Common Stock in the
over-the-counter market at a price of $1.06 per share.
C. On October 5, 1999, LFC sold 8,000 shares of Common Stock in the
over-the-counter market at a price of $1.01 per share.
D. On October 6, 1999, LFC sold 8,500 shares of Common Stock in the
over-the-counter market at a price of $1.00 per share.
E. On October 7, 1999, LFC sold 5,500 shares of Common Stock in the
over-the-counter market at a price of $1.06 per share.
F. On October 8, 1999, LFC sold 18,500 shares of Common Stock in the
over-the-counter market at a price of $1.00 per share.
G. On October 11, 1999, LFC sold 7,000 shares of Common Stock in the
over-the-counter market at a price of $1.00 per share.
H. On October 12, 1999, LFC sold 2,000 shares of Common Stock in the
over-the-counter market at a price of $1.00 per share.
I. On October 13, 1999, LFC sold 3,000 shares of Common Stock in the
over-the-counter market at a price of $0.97 per share.
J. On October 13, 1999, LFC sold 2,000 shares of Common Stock in the
over-the-counter market at a price of $1.03 per share.
K. On October 14, 1999, LFC sold 15,000 shares of Common Stock in the
over-the-counter market at a price of $0.91 per share.
L. On October 18, 1999, LFC sold 15,000 shares of Common Stock in the
over-the-counter market at a price of $0.77 per share.
M. On October 18, 1999, LFC sold 5,000 shares of Common Stock in the
over-the-counter market at a price of $0.88 per share.
7
<PAGE> 8
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: November 4, 1999 LIVIAKIS FINANCIAL COMMUNICATIONS, INC.
By: /s/ John M. Liviakis
----------------------------------------
John M. Liviakis, President
/s/ John M. Liviakis
--------------------------------------------
John M. Liviakis
/s/ Renee A. Liviakis
--------------------------------------------
Renee A. Liviakis
